.AstraZeneca has actually shared an early take a look at the performance of its own in-house antibod...
.After declaring a phase 3 launch based on good midstage end results, iTeos as well as GSK are final...
.The FDA ought to be actually extra open and joint to release a surge in commendations of uncommon a...
.It is actually an uncommonly active Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara R...
.Atea Pharmaceuticals' antiviral has neglected another COVID-19 trial, however the biotech still sto...
.Neurocrine Biosciences' schizophrenia program pivot has actually failed. The biotech was actually i...
.Sanofi has actually made a late entry to the radioligand gathering, paying 100 thousand euros ($ 11...
.After F2G's 1st attempt to get a new course of antifungal to market was hindered due to the FDA, th...
.Moderna has pledged to reduce R&D investing by $1.1 billion through 2027. The decision to retrac...
.Merely four months after Sanofi wager $80 thousand in beforehand money on Pivot Therapies' losmapim...